Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
   Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

Contact Us
My Privacy

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

  Print-friendly version

   Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

---

Preclinical Therapeutics Development for NeuroAIDS (R03)
Release Date: February 16, 2006
Announcement Number: PA-06-140
Application Receipt Date:
May 1, 2006   

Funding Contact: NINDS Funding
Program Area: Neural Environment

Brief Description:
The purpose of this Program Announcement is to encourage the development and/or validation of new in vitro and in vivo models of HIV or HAART-related neurotoxicity that show promise for use in the screening of novel CNS and PNS-targeted therapeutic compounds. Ideally, such models would facilitate the screening of compounds or therapeutic approaches which protect neuronal and glial cells of the CNS from damage in response to HIV and possibly other stresses, such as injury or associated inflammatory insults.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives